Abstract
The number of patients taking two or more medicines with moderate or high anticholinergic activity increased by around 10% at the beginning of the COVID-19 pandemic and has not returned to pre-pandemic levels, show NHS data analysed by The Pharmaceutical Journal. In a trend that experts have described as “worrying”, between January–March 2020 and April–June […]
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call